The prospect of a widely available severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine is an increasingly high priority for an effective response to the coronavirus disease 2019 (COVID-19) pandemic and an area of intense interest and attention for professionals, politicians, and the public alike. The understandable desire for such a vaccine has led to significant discussion and even some planning for the possibility of human challenge studies (HCS) as a tool for accelerating the process for identifying, testing, and developing an effective vaccine (1⇓–3).

中文翻译：

---

意见：就目前而言，将人类挑战性研究用于SARS-CoV-2疫苗的开发是不道德的[医学]

有效应对2019年冠状病毒病（COVID-19）大流行，广泛使用的严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2）疫苗的前景日益重要，并且引起了专业人员的广泛关注和关注，政客和公众。这种疫苗可以理解的愿望，导致显著的讨论，甚至一些规划对人类的挑战研究（HCS）作为加速过程中识别，测试和开发有效的疫苗工具的可能性（1 ⇓ - 3）。